| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 71,963 | 69,658 | 67,032 | 62,644 | | Cost of Revenue | 59,142 | 56,703 | 54,158 | 52,369 | | | Gross Profit | 12,821 | 12,955 | 12,874 | 10,275 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,697 | 6,280 | 5,861 | 5,930 | | Non Recurring |
-
|
-
| 2,745 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,124 | 6,675 | 4,268 | 4,345 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 44 | 136 | 22 | (22) | | Earnings Before Interest And Taxes | 6,168 | 6,811 | 4,290 | 4,323 | | Interest Expense | 1,257 | 1,229 | 1,290 | 1,557 | | Income Before Tax | 4,911 | 5,582 | 3,000 | 2,766 | | Income Tax Expense | 1,479 | 1,597 | 148 | 1,160 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,432 | 3,985 | 2,852 | 1,606 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 33 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,432 | 3,985 | 2,885 | 1,606 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,432 | $3,985 | $2,885 | $1,606 |
|
0.51% Nasdaq 
Income Statement
